What hip osteoarthritis actually feels like

Most people with hip osteoarthritis (hip OA) notice something unremarkable at first — a dull ache in the groin after a long walk, or stiffness that takes a few minutes to ease when getting out of a chair in the morning. At this stage, the discomfort typically fades with rest, and it is easy to attribute it to a pulled muscle or the general wear of getting older.

The location of the pain is an important clue. Hip OA most commonly produces aching in the groin or front of the thigh, and it can radiate into the buttock, outer thigh, and occasionally as far as the knee. This pattern helps distinguish hip-source pain from problems in the lower back, which tends to produce symptoms further down the leg rather than deep in the groin.

Another early sign is a gradual loss of range of motion, particularly on rotating the hip inwards — the movement involved in putting on socks or shoes, or swinging the leg into a car. Painless clicking or grinding (crepitus) and a sense of stiffness after rest are characteristic of early-to-moderate disease.

What changes as the condition advances is the relationship between pain and activity. In early hip OA, pain is reliably triggered by movement and settles with rest. In more advanced disease, pain becomes constant — present at night in bed and on waking — and is no longer reliably relieved by lying still. This shift from activity-related to rest pain is one of the clearest signals that the hip joint is under significant stress.

It is worth knowing that structural changes within the joint — cartilage thinning and early bone spur formation — can begin years before symptoms become noticeable. This is not cause for alarm; it simply means that a scan may show more change than the level of current pain would suggest.

How doctors stage hip osteoarthritis

Staging gives clinicians a shared language — but understanding it also helps patients make sense of the letters and radiology reports that follow an X-ray appointment.

The Kellgren-Lawrence scale

The most widely used radiographic system is the Kellgren-Lawrence (KL) scale, which runs from 0 to 4:

• KL 0 — no visible changes; a normal-appearing joint on X-ray.
• KL 1 — possible early bone spur formation; no firm diagnostic conclusion.
• KL 2 — definite bone spurs and mild joint space narrowing; this is the conventional threshold for a radiographic diagnosis of hip OA.
• KL 3 — marked narrowing, multiple osteophytes, early subchondral sclerosis, and possible cysts.
• KL 4 — severe narrowing with near-complete cartilage loss, dense sclerosis, large bone cysts, and structural deformity of the joint.

A KL 4 report describes what clinicians mean by end-stage disease — the point at which joint replacement typically enters the conversation.

The four-stage clinical model

Alongside radiology, a four-stage model maps how the joint behaves day-to-day: Stage 1 (Minor) involves almost no symptoms and near-normal joint space; Stage 2 (Mild) brings mild pain after activity and visible bone spurs on X-ray; Stage 3 (Moderate) causes significant discomfort with sustained walking or kneeling; Stage 4 (Severe/End-Stage) involves constant pain, bone-on-bone contact, and difficulty managing daily tasks.

The OARSI system — a specialist tool

Specialists occasionally reference the OARSI grading system, which separates cartilage depth loss (grade) from how far the damage has spread horizontally across the joint surface (stage). This distinction matters in research and surgical planning but is less commonly seen in standard patient letters.

A critical caveat: grade does not equal pain

Radiographic severity and symptom severity do not always align. Some patients with KL 3 changes remain relatively comfortable; others with milder structural findings report significant functional disruption. Clinical examination markers — particularly pain when the hip is rotated inwards, reduced flexion, and joint line tenderness — often provide as much information as imaging, especially in early disease when X-ray changes are subtle.

Risk factors that speed up progression

Two people of the same age and activity level can show very different rates of joint deterioration — the reasons are partly structural, partly lifestyle-related, and partly a matter of how and when the condition declares itself.

Structural loading problems

Femoroacetabular impingement (FAI) occurs when the ball or socket of the hip has an irregular shape, generating abnormal friction during movement that gradually damages the labrum and articular cartilage. FAI is thought to contribute to hip OA in up to 50% of cases; in a long-term study of more than 1,000 FAI patients, the mean time from diagnosis to OA development ranged from 15 to 18.7 years — significantly shorter in those with higher BMI or diabetes.

Hip dysplasia — where the socket does not fully cover the femoral head — concentrates joint load onto a reduced contact area, accelerating wear. In dysplasia cohorts, around 45% of patients have been found to present at an advanced OA stage by the time of diagnosis, reflecting the accumulated cost of undetected structural abnormality over many years.

Childhood hip conditions — including Perthes' disease and slipped capital femoral epiphysis (SCFE) — alter joint geometry in ways that raise long-term OA risk into adult life.

Modifiable factors

Obesity is the single largest modifiable risk factor. A dose-response meta-analysis found that each 5-unit increase in BMI corresponds to approximately 11% greater hip OA risk. Weight gain since early adulthood carries independent risk over and above current BMI: one study found that gaining weight since age 20 more than doubled the odds of presenting at a more advanced OA stage at diagnosis (odds ratio 2.02).

It is also worth noting that symptomatic hip OA is more frequently identified in women, while radiographic hip OA is more common in men — a distinction that may influence when the condition comes to clinical attention, rather than indicating that one group faces consistently higher overall risk.

None of these factors makes deterioration inevitable; they identify where closer monitoring and earlier specialist review are most likely to make a meaningful difference.

Managing early and intermediate hip OA

Active management at the minor-to-moderate stages changes the outcome for many patients — and this phase of the condition is often where the most meaningful functional gains are made.

Exercise: the core intervention

OARSI guidelines are unambiguous: both land-based and aquatic structured exercise are first-line treatments for hip OA regardless of how advanced the radiographic changes appear. Strengthening the muscles around the hip joint reduces mechanical load, improves movement quality, and reduces pain — not as a temporary measure while something else is arranged, but as the primary management strategy. The evidence base here is unusually clear, and dismissing this as 'just physio' undersells what a well-structured programme can achieve.

Education and self-management

Understanding that hip OA is a condition that can be managed and stabilised — rather than one that inevitably deteriorates — is itself a recognised component of care. Patients who understand how to pace activity, which movements to adapt, and how to distinguish productive from counterproductive rest tend to do better over time.

Weight management and activity modification

For patients carrying excess weight, reducing BMI reduces joint load and affects symptom severity directly. Activity modification — replacing high-impact loading with lower-impact alternatives such as cycling or swimming — helps manage pain without allowing deconditioning to compound the problem.

Injections as part of the pathway

Intra-articular injections — including corticosteroid, hyaluronic acid, and platelet-rich plasma (PRP) — can provide useful symptom relief at moderate stages and bridge towards further management. They are one tool within a broader plan; they do not alter the underlying structural course of the disease.

The escalation trigger

If three to six months of structured conservative care leaves pain and function significantly disrupting daily life, a specialist assessment is the appropriate next step — to clarify stage, explore further options, and determine whether investigation or a different treatment pathway is warranted.

End-stage hip OA and when hip replacement becomes the right option

Reaching KL Grade 4 / Stage 4 means something specific in day-to-day terms: pain that does not settle with rest, discomfort that wakes patients at night, and a shrinking radius of what is physically manageable. Getting in and out of a car, walking to the end of the street, or managing a flight of stairs can all become consistently effortful rather than occasionally uncomfortable.

When non-surgical options have run their course

The NHS indication for hip replacement is broadly consistent across clinical guidance: persistent pain that has not responded adequately to non-surgical management, combined with restricted mobility that significantly limits daily life, and a clinical picture consistent with end-stage disease. Crucially, both criteria need to be present — imaging alone, even a KL 4 report, does not determine the decision. Symptom severity and functional impact carry equal weight alongside the X-ray findings.

For patients who do meet those criteria, the evidence for proceeding is strong. The PROHIP randomised controlled trial, published in the New England Journal of Medicine in 2024, found that total hip replacement produced a mean 15.9-point improvement in Oxford Hip Score at six months, compared with 4.5 points in the resistance-training group — a difference that is clinically meaningful, not marginal.

Delaying surgery carries its own risks

Patients who postpone replacement beyond the point where it is clinically indicated risk progressive loss of muscle bulk, further functional decline, and a rehabilitation trajectory that starts from a weaker baseline. At the appropriate stage, hip replacement is not a procedure of last resort — it is the most effective intervention the evidence supports.

Surgical technique matters too: options such as SPAIRE hip replacement, which preserves the short external rotator muscles and hip capsule, may support faster early rehabilitation in suitable candidates — a consideration worth exploring in a specialist consultation.

Lincolnshire Hip accepts patients without referral for hip assessment.

Why progression varies and what to realistically expect

Progression is perhaps the question patients ask most, and the honest answer is that the evidence does not support a fixed timeline. Some hip joints move from Stage 2 to Stage 4 within two to three years; others remain at the same radiographic grade for a decade with no meaningful functional change. The factors already explored — body weight, underlying structural morphology, activity load, and how promptly conservative management begins — influence rate of change more than the staging category alone.

The mismatch between imaging and symptoms is real, and not a clinical anomaly. A patient with KL Grade 3 changes can function considerably better day-to-day than another with KL Grade 2, depending on muscle strength, habitual movement patterns, and individual pain sensitivity. The grade on a radiology report describes what the joint looks like structurally; it does not predict next week's pain level or next year's trajectory.

Periods of apparent stability are also genuine. Hip OA tends to progress episodically rather than in a smooth downward curve — a period of relative calm between flares is not false reassurance.

What active monitoring provides in practice is a structured reassessment — combining a functional review with imaging where indicated — that allows a clinician to identify whether the structural picture is shifting. For hip OA specifically, where the interval between early structural changes and clinically significant arthritis can span fifteen years or more in some patients, recognising an inflection point early is what distinguishes timely intervention from a decision made either too soon or too late.

1. [1] Cartilage Autophagy Dysregulation During OA Progression in Hip FAI. (2025). https://doi.org/10.1093/jhps/hnaf011.082 https://doi.org/10.1093/jhps/hnaf011.082
2. [2] Radiographic Classification of Osteoarthritis – Wikipedia. https://en.wikipedia.org/?curid=44226936 https://en.wikipedia.org/?curid=44226936
3. [3] Automated Risk Stratification of Hip OA Development in FAI Patients (Rochester Epidemiology Project). (2021). https://doi.org/10.1177/23259671211050613 https://doi.org/10.1177/23259671211050613
4. [4] Staging of Hip Osteoarthritis for Clinical Trials on Femoroacetabular Impingement. (2013). https://doi.org/10.5435/JAAOS-21-07-S33 https://doi.org/10.5435/JAAOS-21-07-S33
5. [5] Factors Associated with Diagnostic Stage of Hip OA Due to Acetabular Dysplasia (Japanese female patients). (2016). https://doi.org/10.1186/s12891-016-1179-4 https://doi.org/10.1186/s12891-016-1179-4